Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Suboxone 12 mg/3 mg Sublingual film EU/1/06/359/016-018 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate | Indivior Europe Limited | — |
| Suboxone 16 mg/4 mg Sublingual tablet EU/1/06/359/005-006 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate | Indivior Europe Limited | — |
| Suboxone 2 mg/0.5 mg Sublingual film EU/1/06/359/007-009 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate | Indivior Europe Limited | — |
| Suboxone 2 mg/0.5 mg Sublingual tablet EU/1/06/359/01-02 |
Naloxone, Buprenorphine | Indivior Europe Limited | — |
| Suboxone 4 mg/1 mg Sublingual film EU/1/06/359/010-012 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate | Indivior Europe Limited | — |
| Suboxone 8 mg/2 mg Sublingual film EU/1/06/359/013-015 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate | Indivior Europe Limited | — |
| Suboxone 8 mg/2 mg Sublingual tablet EU/1/06/359/03-04 |
Buprenorphine hydrochloride, NALOXONE HYDROCHLORIDE | Indivior Europe Limited | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.